» Articles » PMID: 14523054

Changes in the Levels of Cerebral and Extracerebral Sterols in the Brain of Patients with Alzheimer's Disease

Overview
Journal J Lipid Res
Publisher Elsevier
Specialty Biochemistry
Date 2003 Oct 3
PMID 14523054
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

24S-hydroxycholesterol is a side-chain oxidized oxysterol formed in the brain that is continuously crossing the blood-brain barrier to reach the circulation. There may be an opposite flux of 27-hydroxycholesterol, which is formed to a lower extent in the brain than in most other organs. Here we measured cholesterol, lathosterol, 24S- and 27-hydroxycholesterol, and plant sterols in four different brain areas of deceased Alzheimer's disease (AD) patients and controls. 24S-hydroxycholesterol was decreased and 27-hydroxycholesterol increased in all the brain samples from the AD patients. The difference was statistically significant in four of the eight comparisons. The ratio of 27-hydroxycholesterol to 24S-hydroxycholesterol was significantly increased in all brain areas of the AD patients and also in the brains of aged mice expressing the Swedish Alzheimer mutation APP751. Cholesterol 24S-hydroxylase and 27-hydroxylase protein was not significantly different between AD patients and controls. A high correlation was observed between the levels of 24S-hydroxycholesterol and lathosterol in the frontal cortex of the AD patients but not in the controls. Most probably the high levels of 27-hydroxycholesterol are due to increased influx of this steroid over the blood-brain barrier and the lower levels of 24S-hydroxycholesterol to decreased production. The high correlation between lathosterol and 24-hydroxycholesterol is consistent with a close coupling between synthesis and metabolism of cholesterol in the frontal cortex of the AD brain.

Citing Articles

The Cross-Talk Between the Peripheral and Brain Cholesterol Metabolisms.

Savulescu-Fiedler I, Dorobantu-Lungu L, Dragosloveanu S, Benea S, Dragosloveanu C, Caruntu A Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996836 PMC: 11853762. DOI: 10.3390/cimb47020115.


Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge.

Darabi S, Charkhat Gorgich E, Moradi F, Rustamzadeh A IBRO Neurosci Rep. 2025; 18:191-199.

PMID: 39906286 PMC: 11791331. DOI: 10.1016/j.ibneur.2025.01.004.


Apolipoprotein B gene expression and regulation in relation to Alzheimer's disease pathophysiology.

Aumont-Rodrigue G, Picard C, Labonte A, Poirier J J Lipid Res. 2024; 65(11):100667.

PMID: 39395793 PMC: 11602985. DOI: 10.1016/j.jlr.2024.100667.


New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer's disease.

Cao Y, Zhao L, Chen Z, Li S Front Neurosci. 2024; 18:1430465.

PMID: 39323915 PMC: 11422391. DOI: 10.3389/fnins.2024.1430465.


Emerging Roles of Bile Acids and TGR5 in the Central Nervous System: Molecular Functions and Therapeutic Implications.

Romero-Ramirez L, Mey J Int J Mol Sci. 2024; 25(17).

PMID: 39273226 PMC: 11395147. DOI: 10.3390/ijms25179279.